Liquid biopsy to identify biomarkers for immunotherapy in hepatocellular carcinoma

The past years have witnessed the vigorous development of immunotherapy, mainly immune checkpoint inhibitors (ICIs) targeting the programmed cell death-1 (PD-1) protein and its ligand, PD-L1, and cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4). Indeed, ICIs have largely revolutionized the manag...

Descripción completa

Detalles Bibliográficos
Autores principales: Ao, Huang, Xin, Zhang, Jian, Zhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686238/
https://www.ncbi.nlm.nih.gov/pubmed/34930486
http://dx.doi.org/10.1186/s40364-021-00348-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8686238/
https://www.ncbi.nlm.nih.gov/pubmed/34930486
http://dx.doi.org/10.1186/s40364-021-00348-y

Ejemplares similares